Skip to main content
    N

    Nano X Imaging Ltd (NNOX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.51
    -0.00 (-0.76%)

    Market Cap: $40.14M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    56%(14/25)
    Avg Surprise
    -24.92%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.14
    Range$-0.14 - $-0.14
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.11-27.3%
    60d ago$-0.10-40.0%
    30d ago$-0.10-40.0%
    7d ago$-0.10-40.0%
    Current$-0.14
    Revenue Consensus
    $5M
    Range$5M - $6M
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.20
    Range$-0.20 - $-0.20
    1 analysts
    Revenue Consensus
    $7M
    Range$7M - $7M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.20---
    Sep 26EST
    		-$-0.14---
    Jun 26
    Reported Jul 20
    		$-0.79$-0.12-558.33%Miss-364.7%
    Mar 26
    Reported Apr 20
    		$-0.20$-0.14-42.86%Miss-33.3%
    Dec 25
    Reported Dec 31
    		$-0.17$-0.15-13.33%Miss+0.0%
    Sep 25
    Reported Nov 20
    		$-0.15$-0.17+11.76%Beat+0.0%
    Jun 25
    Reported Aug 12
    		$-0.17$-0.15-13.33%Miss-21.4%
    Mar 25
    Reported May 22
    		$-0.15$-0.15+0.00%Beat+28.6%
    Dec 24
    Reported Mar 31
    		$-0.17$-0.15-13.33%Miss+5.6%
    Sep 24
    Reported Nov 21
    		$-0.15$-0.15+0.00%Beat+59.5%
    Jun 24
    Reported Aug 20
    		$-0.14$-0.15+6.67%Beat+54.8%
    Mar 24
    Reported May 28
    		$-0.21$-0.26+19.23%Beat+0.0%
    Dec 23
    Reported Mar 14
    		$-0.18$-0.30+40.00%Beat+79.1%
    Sep 23
    Reported Nov 28
    		$-0.37$-0.30-23.33%Miss+0.0%
    Jun 23
    Reported Aug 17
    		$-0.31$-0.26-19.23%Miss+18.4%
    Mar 23
    Reported May 22
    		$-0.21$-0.34+38.24%Beat+48.8%
    Dec 22
    Reported Mar 9
    		$-0.86$-0.43-100.00%Miss-91.1%
    Sep 22
    Reported Nov 10
    		$-0.37$-0.42+11.90%Beat-32.1%
    Jun 22
    Reported Aug 16
    		$-0.38$-0.25-52.00%Miss-111.1%
    Mar 22
    Reported May 19
    		$-0.41$-0.22-86.36%Miss-173.3%
    Dec 21
    Reported Mar 31
    		$-0.45$-0.33-36.36%Miss-150.0%
    Sep 21
    Reported Nov 17
    		$-0.28$-0.28+0.00%Beat-115.4%
    Jun 21
    Reported Aug 10
    		$-0.18$-0.20+10.00%Beat-800.0%
    Mar 21
    Reported May 11
    		$-0.15$-0.27+44.44%Beat+70.6%
    Dec 20
    Reported Mar 2
    		$-0.18$-0.20+10.00%Beat-
    Sep 20
    Reported Nov 9
    		$-0.13N/A+51.85%Beat-
    Jun 20
    Reported Jul 31
    		$-0.02N/A+91.30%Beat-
    Dec 19
    Reported Jan 14
    		$-0.51$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.39EV/EBITDAN/A
    Price/FCF-0.67xFCF Yield-149.19%
    Profitability
    Profit Margin0.00%Operating Margin-355.30%
    ROE-99.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio2.84xQuick Ratio2.59x
    Trading Statistics
    Beta1.26Avg Volume850.43K
    52-Week High$4.7152-Week Low$0.50

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.58
    SMA 20$0.64
    SMA 50$0.78
    SMA 200$1.75
    EMA 10$0.57
    EMA 20$0.63
    EMA 50$0.79
    EMA 200$1.72

    MACD

    Line: -0.07Signal: -0.07Hist: -0.01

    ADX

    ADX: 24.5+DI: 13.0-DI: 29.2

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down100.0
    PSAR$0.63

    Bollinger Bands

    Upper Band$0.80
    Lower Band$0.48
    %B Position5040%(Upper)
    Band Width0.10

    RSI (14-Day)

    Oversold
    28.6

    Momentum Oscillators

    Stoch %K5.0
    Stoch %D4.7
    Williams %R-95.5
    ROC (10d)-26.4%
    Momentum-0.18
    CCI (20d)-140.1
    MFI (14d)21.9

    Volatility Measures

    ATR (14d)$0.05(10.6%)
    StdDev (20d)0.08
    Hist Vol56.4%(High)

    Volume Flow

    VWAP$0.51
    OBV-49.6M
    AD Line-58.3M
    CMF (20d)-0.454

    Volume Metrics

    Avg Vol (20d)810.7K
    Vol Ratio0.7x
    VWMA (20d)$0.64

    Pivot Points

    R3$0.55
    R2$0.54
    R1$0.53
    Pivot Point$0.51
    S1$0.50
    S2$0.49
    S3$0.48

    Advanced Oscillators

    TSI-33.46
    Ultimate Osc26.2
    KST-257.06

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$4.16M$4.31M$3.72M$3.45M$3.04M$2.81M$3.00M$3.03M$2.70M$2.55M$2.40M$2.48M
    Cost of Revenue$47.83M$7.01M$7.63M$6.33M$6.28M$5.86M$5.89M$5.84M$5.55M$4.70M$4.11M$4.14M
    Gross Profit$-43,674,000$-2,698,000$-3,913,000$-2,882,000$-3,240,000$-3,049,000$-2,890,000$-2,812,000$-2,853,000$-2,151,000$-1,716,000$-1,662,000
    Operating Expenses$11.80M$12.09M$12.55M$11.35M$11.25M$11.04M$17.98M$11.33M$11.46M$10.93M$11.54M$12.89M
    R&D$4.71M$4.84M$4.84M$4.59M$4.83M$4.98M$5.40M$4.75M$4.81M$5.22M$6.81M$6.04M
    SG&A$5.44M$5.24M$7.89M$5.28M$5.13M$5.14M$6.56M$5.71M$5.92M$5.04M$5.53M$5.05M
    Operating Income$-55,478,000$-14,790,000$-16,500,000$-14,235,000$-14,491,000$-14,090,000$-14,975,000$-14,139,000$-14,507,000$-13,084,000$-13,256,000$-21,993,000
    Interest Income$0$369,000$351,000$457,000$0$765,000$820,000$404,000$856,000$790,000$360,000$511,000
    Interest Expense$60,000$0$18.57M$0$149,000$0$0$0$0$0$0$0
    Income Before Tax$-55,538,000$-14,189,000$-35,067,000$-13,778,000$-14,640,000$-13,325,000$-14,155,000$-13,733,000$-13,651,000$-12,335,000$-10,327,000$-21,482,000
    Income Tax Expense$-51,000$76,000$-1,694,000$-94,000$82,000$-86,000$0$-94,000$-76,000$-94,000$-79,000$-79,000
    Net Income$-55,487,000$-14,265,000$-33,372,999$-13,684,000$-14,722,000$-13,239,000$-14,061,000$-13,639,000$-13,575,000$-12,241,000$-10,248,000$-21,403,000
    EBITDA$-52,659,000$-11,971,000$-14,070,000$-11,277,000$-11,542,000$-11,147,000N/A$-11,208,000$-11,535,000$-10,186,000$-7,571,000$-11,659,000
    EBIT$-55,478,000$-14,790,000$-16,917,000$-14,235,000$-14,491,000$-14,090,000N/A$-14,139,000$-14,463,000$-13,125,000$-10,572,000$-14,556,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NNOX

    News

    Nanox.AI signs distribution deal for bone health software in Italy

    Nanox AI Ltd., a subsidiary of Nano-X Imaging Ltd. (NASDAQ: NNOX), has secured a distribution agreement with Technologic s.r.l. to commercialize its HealthOST bone health software in Italy. HealthOST analyzes routine CT...

    Investing.com Canada•10/16/26•Somewhat-Bullish

    Nanox AI Ltd. Enters into Distribution Agreement with Technologic s.r.l., an Affiliate of Tecnologie Avanzate, to Commercialize Nanox.AI Bone Solution in Italy

    Nanox AI Ltd. has signed a distribution agreement with Technologic s.r.l., an affiliate of Tecnologie Avanzate...

    Yahoo Finance•10/16/26•Bullish

    Nano-X Imaging unit signs Italy distribution deal for bone health AI tool

    Nano-X Imaging Ltd.'s subsidiary, Nanox AI Ltd., has signed a distribution agreement with Technologic s.r.l. to commercialize its AI-based bone health product, HealthOST...

    StreetInsider•10/16/26•Bullish

    Nanox Selected as One of TIME’s Best Inventions of 2026 for its Nanox.ARC X

    Nanox Imaging Ltd. (NASDAQ: NNOX) announced that its Nanox.ARC X system has been selected as one of TIME’s Best Inventions of 2026 for its role in making advanced medical imaging more accessible. This marks Nanox's...

    GlobeNewswire•10/15/26•Bullish

    TIME picks an X-ray system that makes 3D views with up to 80% less radiation than CT for the same body parts.

    Nanox Imaging (NNOX) announced that its Nanox.ARC X medical imaging system has been selected for TIME's Best Inventions of 2026 list...

    Stock Titan•10/15/26•Bullish

    NNOX Valuation and Fair Value

    P/E
    -0.4x
    P/FCF
    -0.7x
    P/B
    0.5x
    See GNG's fair value

    NNOX Profitability: Margins, ROIC and FCF

    Gross margin
    -340.1%
    Operating margin
    -355.3%
    Net margin
    0.0%
    ROE
    -99.0%
    FCF margin
    -340.8%
    FCF yield
    -149.2%

    NNOX Competitors

    CompanyTicker
    Instil Bio Inc.TIL
    Grace Therapeutics, Inc.GRCE
    Precipio IncPRPO
    Scynexis IncSCYX
    Ekso Bionics Holdings IncEKSO
    CVRx IncCVRX
    PureTech Health PLCPRTC
    FibroGen IncFGEN

    Sector: Healthcare

    NNOX Analyst Ratings

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    0
    Buy
    2
    Hold
    1
    Sell
    0
    Strong Sell
    0

    NNOX Bull Case vs Bear Case

    Bull case

    • NNOX grew quarterly revenue 36.7% year over year.

    Bear case

    • NNOX beat EPS estimates in 12.5% of its last 8 reported quarters.

    NNOX Earnings: Beat Rate and Next Report

    Beat rate
    1 of 8 quarters (12.5%)
    Average surprise
    -78.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.14
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About NNOX

    Does NNOX pay dividends?

    Nano X Imaging Ltd (NNOX) does not currently pay a regular dividend.

    What is NNOX's market cap?

    Nano X Imaging Ltd (NNOX) has a market capitalization of $40.14M with a current stock price of $0.51.

    Related stocks

    Sector: Healthcare

    All stocks starting with N

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In